Facebook

Launching Genomic Medicine into Clinical Practice ― Novel, Challenge and Change ―   JSMO2019 2019 the Japanese Society of Medical Oncology Annual Meeting  July 18-20, 2019

Venue: Kyoto International Conference Center Grand Prince Hotel Kyoto   Congress President: Yasuhiro Fujiwara National Cancer Center Hospital, Japan

Poster Download

dl_poster_en

Meet the Experts

We planned to hold "Meet the Experts" sessions in JSMO2019. Each session is 60 minutes, and we have about 17 sessions during the conference from July 18 (Thu.) to 20 (Sat.).

Pre-registration Required(Free of Charge)

* Registration starts in late May

Meet the Experts Overview

Meet the Experts session is a 60-minute small session constituted by an expert, a moderator and around 15-20 participants. The expert who delivers a lecture is a member of "International Steering Committee" organized by JSMO, and the members were selected as a well-known excellent doctor from the main facilities related to cancer in each country.

The purpose of this session is to provide an opportunity to talk to the experts of their research field frankly, and to exchange the participants' opinions freely.

We would like to offer you free registration to congratulate our first time of holding such sessions in JSMO conference. To participate in the session, pre-registration is required since the seats for each session are limited. The pre-registration will be available in late May.

Come to visit our website around the time and do not miss the chance to find your mentor!

Experts and Theme of Their Talk

Further details such as the session date will be announced later.

Experts Theme of Talk

Prof. Keunchil Park

Samsung Medical Center,
Sungkyunkwan University School of Medicine, Korea

Evolving Management Paradigm of Advanced NSCLC

Prof. Yi-Long Wu

Guangdong Lung Cancer Institute, China

Liquid Biopsy for NSCLC: from research to practice

Prof. James Chih-Hsin Yang

Graduate Institute of Oncology,
National Taiwan University, Taiwan

Systemic approach to clinical trial result interpretation

Prof. Pasi A. Jänne

Dana-Farber Cancer Institute, U.S.A

New therapeutic strategies for EGFR mutant lung cancer

Prof. Sun Young RHA

Yonsei Cancer Center, Yonsei University College of Medicine, Korea

Immuno-precision medicine in gastric cancer; How to select the proper patients?

Prof. Tae Won Kim

Asan Medical Center, Korea

Multimodality treatment of rectal cancer

Dr. Li-Tzong Chen

National Institute of Cancer Research /
National Health Research Institutes, Taiwan

Interpreting the results of adjuvant trials in resectable pancreatic cancer

Dr. Ian Chau

Royal Marsden Hospital, UK

Development of immunotherapy in gastro-esophageal cancer in the worldwide arena

Prof. Zev A. Wainberg

UCLA School of Medicine, U.S.A

Novel targeted therapies in gastric cancer, moving beyond PD1

Dr. Yoon-Sim YAP

National Cancer Centre Singapore, Singapore

Breast cancer in the East versus the West; followed by interactive session on establishing collaborations

Prof. Sibylle Loibl

GBG Forschungs GmbH, Goethe University Frankfurt/M, Clinical Consultant Centre for Hematology and Oncology/Bethanien Frankfurt/M, Germany

How to implement personalized medicine

Prof. Hope S. Rugo

UCSF Helen Diller Family Comprehensive Cancer Center, U.S.A

Evolving strategies for enhancing the impact of immunotherapy in breast cancer

Dr. William Hwang

National Cancer Centre Singapore, Singapore

Latest advances in hematopoietic stem cell transplantation

Prof. Thierry R. FACON

Lille University Hospital, France

Treatment Strategies for Newly diagnosed elderly patients with Multiple Myeloma

Prof. Jorge E. Cortes

The University of Texas M.D. Anderson Cancer Center, U.S.A

Novel therapies for AML

Prof. Thomas Gajewski

University of Chicago, U.S.A

TBD

Dr. Etienne GC BRAIN

Department of Medical Oncology,
Institut Curie - Hôpital René Huguenin, France

Frailty and challenges of immunotherapy in older patients

Pagetop